BTIG and H.C. Wainwright & Co. are acting as co-lead managers with D. Boral Capital acting as co-manager for the offering.

2024 has seen some extreme changes to sector valuations. Technology and financial valuations are trading at twenty-year highs ...

D. Boral Capital keeps a Buy rating on Anavex Life Sciences (AVXL) with a $46 price target after Cassava Sciences’ (SAVA) Phase 3 trial for simufilam in mild-to-moderate Alzheimer’s disease ...

India's electrical and electronics industry aims to reach USD 130 billion by 2030. ELECRAMA 2025, the world's largest electrical show, will be held in Greater Noida. Over 1,100 exhibitors and 15,000 ...

It’s that time of the year again, when fund managers down tools to reflect on the big themes of 2024. As it turned out, 2024 ...

Craft Capital Management LLC acted as the representative of the underwriters, with D. Boral Capital LLC acting as the co-underwriter, for the Offering. The common shares of the Offering referenced ...

The Products & Platforms segment comprises the HCLTech Software Division, Actian software, Industry Software Division, and an IP partnership with DXC, which together account for a significant part of ...

Hair thinning can happen to anyone, no matter their sex or age. Luckily, certain hair growth products are available with ingredients that can help slow down or even reverse the thinning process ...

According to relationship and mental health experts, "bright siding" happens all the time, and it's something people often do with good intentions. Still, it can have disastrous consequences by ...

D. Boral Capital lowered the firm’s price target on Carisma Therapeutics (CARM) to $12 from $24 and keeps a Buy rating on the shares after the company announced it is discontinuing the ...